Atria (ATRAV) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Achieved record-high adjusted EBIT of EUR 65.4 million in 2024, up EUR 15.8 million year-over-year, with all business areas improving results.
Net sales reached EUR 1,755.4 million, slightly above the previous year, driven by growth in Sweden and Estonia, offsetting declines in Finland.
New poultry plant in Finland fully commissioned, enhancing production efficiency.
Board proposes a dividend of EUR 0.69 per share for 2024.
Major strategic moves included the acquisition of Gooh! in Sweden and divestment of Best-In Oy in Finland.
Financial highlights
2024 net sales reached EUR 1,755.4 million, up 0.2% year-over-year.
Adjusted EBIT margin improved to 3.7% from 2.8% in 2023.
Adjusted EPS rose to EUR 1.38 from EUR 0.98 year-over-year.
Free cash flow turned positive at EUR 41.6 million, compared to EUR -12.5 million in 2023.
Equity ratio increased to 43.2% from 41.7% year-over-year.
Outlook and guidance
Adjusted EBIT for 2025 expected to be lower than 2024's record EUR 65.4 million.
Geopolitical instability, new nutrition guidelines, and labor negotiations may impact 2025 performance.
Despite challenges, strong brands and efficient operations provide a stable foundation.
Latest events from Atria
- Record net sales and EBIT, major investments, and positive 2026 outlook despite market risks.ATRAV
Q4 202512 Feb 2026 - Q3 2025 saw broad-based sales and EBIT growth, major investments, and a raised EBIT outlook.ATRAV
Q3 202523 Oct 2025 - Net sales and EBIT rose, driven by Sweden and poultry efficiency, but 2025 outlook is cautious.ATRAV
Q2 202517 Jul 2025 - Adjusted EBIT up 30% year-over-year, driven by Sweden's growth and operational efficiency.ATRAV
Q3 202413 Jun 2025 - Profitability gains and operational improvements led to a raised EBIT outlook for 2024.ATRAV
Q2 202413 Jun 2025 - EBIT and net sales rose, but 2025 outlook is cautious amid geopolitical and labor risks.ATRAV
Q1 20255 Jun 2025